Asio Capital, LLC Bristol Myers Squibb CO Transaction History

Asio Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $18,444 - $22,116	-300 Reduced 6.17%	4,562 $333,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $2.89 Million - $3.37 Million	-53,932 Reduced 91.73%	4,862 $303,000
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $82,956 - $97,172	1,402 Added 2.44%	58,794 $3.48 Million
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $89,521 - $97,489	-1,446 Reduced 2.46%	57,392 $3.84 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $1.21 Million - $1.36 Million	20,363 Added 52.93%	58,838 $3.71 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $442,692 - $501,651	7,667 Added 24.89%	38,475 $2.39 Million
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $259,296 - $287,334	4,515 Added 17.17%	30,808 $1.86 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $1.44 Million - $1.69 Million	26,293 New	26,293 $1.55 Million
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $1,392 - $2,022	-30 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $1,476 - $1,925	30 New	30 $1,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Asio Capital, LLC with notifications on news.